At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
01877 JUNSHI BIO
Trading 07-03 10:30:12
11.600
+0.120
+1.05%
High11.740
Low11.580
Vol93.80K
Open11.720
D1 Closing11.480
Amplitude1.39%
Mkt Cap11.43B
Tradable Cap2.54B
Total Shares985.69M
T/O1.09M
T/O Rate0.04%
Tradable Shares219.30M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Shanghai Junshi Biosciences Breast Cancer Drug Obtains DRC from NMPA; Shares Jump 8%
retail investors who own 51% along with institutions invested in Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) saw increase in their holdings value last week
Shanghai Junshi Biosciences Co Ltd is a China-based company mainly engaged in innovation-driven biopharmaceutical business. The Company develops innovative drugs and provides clinical research commercialization services worldwide. The Company mainly provides its products in the treatment of tumor immunotherapy, metabolic diseases, inflammation or autoimmune diseases, as well as nervous system diseases. The Company's products are mainly used to treat melanoma, nasopharyngeal cancer, esophageal cancer, urothelial cancer, malignant lymphoma and others. The Company provides its products for domestic and overseas markets.